ÂÜÀòÂÒÂ×

Bennett M. (Mike) Butters has served as a Director of the Company since its inception in February 2002. He led the early concept and design efforts for the development of the Company’s platform technology, including production of the system for recording and optimizing the Company’s molecular signals known as the Molecular Interrogation and Data System (MIDS). Mike brings particular technological expertise to the Board’s analysis and discussions. He also continues to assist the Company in its operations, having pioneered new concepts in signal acquisition, post signal processing, and signal transduction. His career in health care in both the private and public sectors, together with his background in electronics and radio frequency design and engineering, has provided a valuable multidisciplinary framework for enabling and executing innovation within the Company.